Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Susanne Eder"'
Autor:
Stefanie Thöni, Felix Keller, Sara Denicolò, Susanne Eder, Lukas Buchwinkler, László Rosivall, Andrzej Wiecek, Patrick Barry Mark, Peter Rossing, Hiddo L. Heerspink, Gert Mayer
Publikováno v:
Kidney & Blood Pressure Research, Vol 48, Iss 1, Pp 165-174 (2023)
Introduction: Type 2 diabetes and its complications represent a huge burden to public health. With this prospective, observational cohort study, we aimed to estimate and to compare the incidence rate (IR) of renal and cardiovascular outcomes and all-
Externí odkaz:
https://doaj.org/article/e4df6b52f8064abbb6c6c84eb5c83022
Autor:
Kawsar R. Talaat, Chad K. Porter, Subhra Chakraborty, Brittany L. Feijoo, Jessica Brubaker, Brittany M. Adjoodani, Barbara DeNearing, Michael G. Prouty, Steven T. Poole, A. Louis Bourgeois, Madison Billingsley, David A. Sack, Susanne Eder-Lingelbach, Christian Taucher
Publikováno v:
Microorganisms, Vol 12, Iss 4, p 727 (2024)
Controlled human infection models are important tools for the evaluation of vaccines against diseases where an appropriate correlate of protection has not been identified. Enterotoxigenic Escherichia coli (ETEC) strain LSN03-016011/A (LSN03) is an LT
Externí odkaz:
https://doaj.org/article/5f3a34f3ebdc48288a3296a738ed5782
Autor:
Sonnal Lohia, Justyna Siwy, Emmanouil Mavrogeorgis, Susanne Eder, Stefanie Thöni, Gert Mayer, Harald Mischak, Antonia Vlahou, Vera Jankowski
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 17, p 13540 (2023)
Type II diabetes mellitus (T2DM) accounts for approximately 90% of all diabetes mellitus cases in the world. Glucagon-like peptide-1 receptor (GLP-1R) agonists have established an increased capability to target directly or indirectly six core defects
Externí odkaz:
https://doaj.org/article/3d4ae650d3c5405c9aacc00412e466f2
Autor:
Christopher Adlbrecht, Raphael Wurm, Pieter Depuydt, Herbert Spapen, Jose A. Lorente, Thomas Staudinger, Jacques Creteur, Christian Zauner, Andreas Meier-Hellmann, Philipp Eller, Margot Vander Laenen, Zsolt Molnár, István Várkonyi, Bernhard Schaaf, Mária Héjja, Vladimír Šrámek, Hauke Schneider, Niranjan Kanesa-thasan, Susanne Eder-Lingelbach, Anton Klingler, Katrin Dubischar, Nina Wressnigg, Jordi Rello
Publikováno v:
Critical Care, Vol 24, Iss 1, Pp 1-10 (2020)
Abstract Background Pseudomonas aeruginosa infections are a serious threat in intensive care units (ICUs). The aim of this confirmatory, randomized, multicenter, placebo-controlled, double-blind, phase 2/3 study was to assess the efficacy, immunogeni
Externí odkaz:
https://doaj.org/article/58fdcb99ef594658b60807f8d9e0d7eb
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Primary surgical repair remains the traditional treatment for patients with critical duct-dependent coarctation of the aorta (CoA). Initial surgical repair might not be possible or associated with higher risks if additional comorbidities arise in sma
Externí odkaz:
https://doaj.org/article/4613d6f294eb4f56b0f71c0f5e669564
Autor:
Susanne Eder, Johannes Leierer, Julia Kerschbaum, Laszlo Rosivall, Andrzej Wiecek, Dick de Zeeuw, Patrick B. Mark, Georg Heinze, Peter Rossing, Hiddo L. Heerspink, Gert Mayer
Publikováno v:
Kidney & Blood Pressure Research, Vol 43, Iss 1, Pp 181-190 (2018)
Background/Aims: The prevalence of diabetes mellitus type 2 and kidney disease in these patients varies widely between European countries. Methods: In addition to store bio-samples the “Prospective cohort study in patients with type 2 diabetes mell
Externí odkaz:
https://doaj.org/article/642de6a7606f4d5189a488d306bca805
Autor:
Johannes Leierer, Paul Perco, Benedikt Hofer, Susanne Eder, Alexander Dzien, Julia Kerschbaum, Michael Rudnicki, Gert Mayer
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13, p 6885 (2021)
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder leading to deterioration of kidney function and end stage kidney disease (ESKD). A number of molecular processes are dysregulated in ADPKD but the exac
Externí odkaz:
https://doaj.org/article/73cc4125f6da43b7a91226e0433181f9
Autor:
Michael Rudnicki, Paul Perco, Hannes Neuwirt, Susie-Jane Noppert, Johannes Leierer, Judith Sunzenauer, Susanne Eder, Carlamaria Zoja, Kathrin Eller, Alexander R Rosenkranz, Gerhard A Müller, Bernd Mayer, Gert Mayer
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e44891 (2012)
Novel prognostic markers for progression of kidney disease are needed to distinguish patients who might benefit from a more aggressive nephroprotective therapy. Expression of the proteoglycan versican was evaluated in renal transcriptomics profiles a
Externí odkaz:
https://doaj.org/article/ce746ac679cb4b7884415000c0dda6d7
Autor:
Sonnal Lohia, Justyna Siwy, Emmanouil Mavrogeorgis, Susanne Eder, Stefanie Thoeni, Gert Mayer, Harald Mischak, Antonia Vlahou, Vera Jankowski
AimType II Diabetes mellitus (T2DM) accounts for approximately 90% of all DM cases in the world; and is diagnosed with increased levels of blood glucose or hyperglycemia. Glucagon-like peptide-1 receptor (GLP-1R) agonists have established an increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::860638ab3609c24ac8020c60025892b9
https://doi.org/10.1101/2023.05.03.23289439
https://doi.org/10.1101/2023.05.03.23289439
Autor:
Rajeka Lazarus, Benedicte Querton, Irena Corbic Ramljak, Shailesh Dewasthaly, Juan Carlos Jaramillo, Katrin Dubischar, Michael Krammer, Petronela Weisova, Romana Hochreiter, Susanne Eder-Lingelbach, Christian Taucher, Adam Finn, Claire Bethune, Marta Boffito, Marcin Bula, Fiona M Burns, Rebecca Clark, Dileep Dasyam, Simon Drysdale, Saul Faust, Effrossyni Gkrania-Klotsas, Christopher Green, Hana Hassanin, Paul Heath, Amardeep Heer, Toby Helliwell, Anil Hormis, Philip Kalra, Ed Moran, John Ndikum, Iain Page, David Price, Nick Probert, Mahadev Ramjee, Tommy Rampling, Harpal S Randeva, Stephen Ryder, John Steer, Emma Thompson, David Torku
Publikováno v:
2022, ' Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE) : interim analysis of a randomised, controlled, phase 3, immunobridging trial ', The Lancet Infectious Diseases, vol. 22, no. 12, pp. 1716-1727 . https://doi.org/10.1016/S1473-3099(22)00502-3, https://doi.org/10.1016/S1473-3099(22)00502-3
BackgroundThe Valneva COVID-19 vaccine (VLA2001; Valneva Austria, Vienna, Austria) is an inactivated whole-virus, adjuvanted SARS-CoV-2 vaccine. We aimed to assess the safety and immunogenicity of primary vaccination with VLA2001 versus the ChAdOx1-S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27f65e657505d72fb360ce88922221cf
https://hdl.handle.net/1983/8151ad0f-2432-43b1-a576-b9932a00559e
https://hdl.handle.net/1983/8151ad0f-2432-43b1-a576-b9932a00559e